Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Veldeman

Showing results (41-50 of 72) with videos related to

Pageof 8
Sort By:
Frontiers in Neurology|September 26, 2022
Seizure after surgical treatment of chronic subdural hematoma-Associated factors and effect on outcomeHussam Hamou, Mohammed Alzaiyani, Tobias Rossmann, et al.
Journal of the Neurological Sciences|June 10, 2021
Levels of bioactive adrenomedullin in plasma and cerebrospinal fluid in relation to delayed cerebral ischemia in patients after aneurysmal subarachnoid hemorrhage: A prospective observational studyMichael Veldeman, Rabia Dogan, Miriam Weiss, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 20, 2025
Systematic review and meta-analysis of transcranial doppler biomarkers for the prediction of delayed cerebral ischemia following subarachnoid hemorrhageHanna Schenck, Céline van Craenenbroeck, Sander van Kuijk, et al.
Acta Neurochirurgica|May 21, 2022
Decompressive hemicraniectomy after aneurysmal subarachnoid hemorrhage-justifiable in light of long-term outcome?Michael Veldeman, Miriam Weiss, Lorina Daleiden, et al.
Journal of the Neurological Sciences|December 22, 2020
Risk profile of decompressive hemicraniectomy for malignant stroke after revascularization treatmentMohamed Alzayiani, Tobias Schmidt, Michael Veldeman, et al.
Journal of Neurointerventional Surgery|June 5, 2024
Long-term risk of hemorrhage and mortality after treatment of high-grade intracranial dural arteriovenous fistulasTobias Rossmann, Michael Veldeman, Elias Oulasvirta, et al.
World Neurosurgery|May 21, 2021
Urea-Creatinine Ratio (UCR) After Aneurysmal Subarachnoid Hemorrhage: Association of Protein Catabolism with Complication Rate and OutcomeWalid Albanna, Miriam Weiss, Michael Veldeman, et al.
Journal of Clinical Medicine|October 16, 2025
A Closer Look at Potential Underlying Factors Related to Possible Disparity Between Sexes in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid HemorrhageMichael Veldeman, Tobias Philip Schmidt, Katharina Seyfried, et al.
Neurosurgical Focus|March 1, 2024
Long-term treatment outcomes and natural course of low-grade intracranial dural arteriovenous fistulasTobias Rossmann, Michael Veldeman, Elias Oulasvirta, et al.
Neurocritical Care|July 5, 2022
Revisiting the Timeline of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Toward a Temporal Risk ProfileTobias Philip Schmidt, Miriam Weiss, Anke Hoellig, et al.
Pageof 8

Showing results (41-50 of 72) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|September 26, 2022
Seizure after surgical treatment of chronic subdural hematoma-Associated factors and effect on outcomeHussam Hamou, Mohammed Alzaiyani, Tobias Rossmann, et al.
Journal of the Neurological Sciences|June 10, 2021
Levels of bioactive adrenomedullin in plasma and cerebrospinal fluid in relation to delayed cerebral ischemia in patients after aneurysmal subarachnoid hemorrhage: A prospective observational studyMichael Veldeman, Rabia Dogan, Miriam Weiss, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|March 20, 2025
Systematic review and meta-analysis of transcranial doppler biomarkers for the prediction of delayed cerebral ischemia following subarachnoid hemorrhageHanna Schenck, Céline van Craenenbroeck, Sander van Kuijk, et al.
Acta Neurochirurgica|May 21, 2022
Decompressive hemicraniectomy after aneurysmal subarachnoid hemorrhage-justifiable in light of long-term outcome?Michael Veldeman, Miriam Weiss, Lorina Daleiden, et al.
Journal of the Neurological Sciences|December 22, 2020
Risk profile of decompressive hemicraniectomy for malignant stroke after revascularization treatmentMohamed Alzayiani, Tobias Schmidt, Michael Veldeman, et al.
Journal of Neurointerventional Surgery|June 5, 2024
Long-term risk of hemorrhage and mortality after treatment of high-grade intracranial dural arteriovenous fistulasTobias Rossmann, Michael Veldeman, Elias Oulasvirta, et al.
World Neurosurgery|May 21, 2021
Urea-Creatinine Ratio (UCR) After Aneurysmal Subarachnoid Hemorrhage: Association of Protein Catabolism with Complication Rate and OutcomeWalid Albanna, Miriam Weiss, Michael Veldeman, et al.
Journal of Clinical Medicine|October 16, 2025
A Closer Look at Potential Underlying Factors Related to Possible Disparity Between Sexes in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid HemorrhageMichael Veldeman, Tobias Philip Schmidt, Katharina Seyfried, et al.
Neurosurgical Focus|March 1, 2024
Long-term treatment outcomes and natural course of low-grade intracranial dural arteriovenous fistulasTobias Rossmann, Michael Veldeman, Elias Oulasvirta, et al.
Neurocritical Care|July 5, 2022
Revisiting the Timeline of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: Toward a Temporal Risk ProfileTobias Philip Schmidt, Miriam Weiss, Anke Hoellig, et al.
Pageof 8